<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="family-medicine" lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher">JOHS</journal-id>
      <journal-id journal-id-type="nlm-ta">Journ of Health Scien</journal-id>
      <journal-title-group>
        <journal-title>Journal of HealthCare Sciences</journal-title>
        <abbrev-journal-title abbrev-type="pubmed">Journ of Health Scien</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2231-2196</issn>
      <issn pub-type="opub">0975-5241</issn>
      <publisher>
        <publisher-name>Radiance Research Academy</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">289</article-id>
      <article-id pub-id-type="doi">http://dx.doi.org/10.52533/JOHS.2024.40905</article-id>
      <article-id pub-id-type="doi-url"/>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Family Medicine</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Strategies for Early Detection and Management of Type 2 Diabetes in Adult Populations&#13;
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Balobaid</surname>
            <given-names>Abdulrahman Nasir</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aloufi</surname>
            <given-names>Nadyah Saud</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alsharif</surname>
            <given-names>Zaid Musaad</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alhejji</surname>
            <given-names>Abdullah Mohammed</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alraddadi</surname>
            <given-names>Shatha Awad</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alamry</surname>
            <given-names>Hilal Faleh</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="ppub">
        <day>12</day>
        <month>09</month>
        <year>2024</year>
      </pub-date>
      <volume>4</volume>
      <issue>9</issue>
      <fpage>379</fpage>
      <lpage>386</lpage>
      <permissions>
        <copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement>
        <copyright-year>2009</copyright-year>
        <license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Type 2 Diabetes Mellitus (T2DM) is marked by insulin resistance and beta-cell dysfunction, contributing to a global health crisis exacerbated by rising obesity, sedentary lifestyles, and aging populations. This review examines strategies for early detection and management of T2DM in adults, highlighting advancements in diagnostic methods such as Glycated Albumin (GA) and Glycated Serum Protein (GSP), which offer improved sensitivity and specificity over traditional HbA1c tests. Continuous Glucose Monitoring (CGM) provides real-time glucose data, enhancing management but facing challenges such as excessive costs and insurance limitations. Effective early detection of prediabetes, combined with lifestyle interventions and pharmacological treatments, plays a crucial role in managing T2DM. Emerging therapies, including advanced medications and bariatric surgery, show promise for improving glycemic control and reducing complications. A multidisciplinary approach, integrating patient education, behavioural changes and innovative technologies, is essential for optimizing management strategies. Addressing these aspects will help mitigate the impact of T2DM and improve patient outcomes globally.&#13;
</p>
      </abstract>
      <kwd-group>
        <kwd>Type 2 Diabetes Mellitus (T2DM)</kwd>
        <kwd> Early Detection</kwd>
        <kwd> Continuous Glucose Monitoring</kwd>
        <kwd> Prediabetes</kwd>
      </kwd-group>
    </article-meta>
  </front>
</article>